These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10072495)

  • 1. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes.
    Busch LK; Bishop GA
    J Immunol; 1999 Mar; 162(5):2555-61. PubMed ID: 10072495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
    J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
    Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
    Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
    Henriquez NV; Floettmann E; Salmon M; Rowe M; Rickinson AB
    J Immunol; 1999 Mar; 162(6):3298-307. PubMed ID: 10092782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
    Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
    Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro.
    Hatzivassiliou EG; Kieff E; Mosialos G
    Leuk Res; 2007 Mar; 31(3):315-20. PubMed ID: 16919331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic-AMP modulates downstream events in CD40-mediated signal transduction, but inhibition of protein kinase A has no direct effect on CD40 signaling.
    Goldstein MD; Cochrane A; Watts TH
    J Immunol; 1997 Dec; 159(12):5871-80. PubMed ID: 9550383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
    Busch LK; Bishop GA
    J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific blockade by CD54 and MHC II of CD40-mediated signaling for B cell proliferation and survival.
    Doyle IS; Hollmann CA; Crispe IN; Owens T
    Exp Cell Res; 2001 May; 265(2):312-8. PubMed ID: 11302697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
    Graham JP; Arcipowski KM; Bishop GA
    Immunol Rev; 2010 Sep; 237(1):226-48. PubMed ID: 20727039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
    Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
    EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.
    Xie P; Hostager BS; Bishop GA
    J Exp Med; 2004 Mar; 199(5):661-71. PubMed ID: 14981114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.
    Panagopoulos D; Victoratos P; Alexiou M; Kollias G; Mosialos G
    J Virol; 2004 Dec; 78(23):13253-61. PubMed ID: 15542676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes.
    Hsing Y; Bishop GA
    J Immunol; 1999 Mar; 162(5):2804-11. PubMed ID: 10072527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Signal transduction and biological characteristics of EB virus-encoded latent membrane protein 1 and its correlation with CD40].
    Tao Y; Zhang XG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):585-90. PubMed ID: 15562778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different CD40-mediated signaling events require distinct CD40 structural features.
    Hostager BS; Hsing Y; Harms DE; Bishop GA
    J Immunol; 1996 Aug; 157(3):1047-53. PubMed ID: 8757608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.